Skip to content

Supporting the response to COVID-19

Review all our resources and activities in relation to COVID-19 here. These pages are regularly updated to reflect new work programmes and virtual events.

Now that our partners across the NHS and social care are mobilised at scale in response to the COVID-19 pandemic, the role of England’s 15 Academic Health Science Networks (AHSNs) is to support them by helping them take full advantage of the most relevant innovations and technologies that can improve care for patients and support our services in this challenging context.

Nationally, the AHSN Network is part of a coordinated NHS response to identify and enable the implementation of technologies that respond to areas of highest priority action, in particular solutions for remote consultation and patient monitoring, diagnostics and point-of-care testing.

Similarly, in our region the West of England AHSN is part of a system-wide approach, led by our regional NHS office, to support our local health and care organisations – connecting them with potential solutions and offering up the specific operational or clinical skill sets of our teams where relevant. This includes our Patient Safety Collaborative, who will be adapting their specialist skills towards keeping patients safe in these very demanding environments.

How to get in touch

All AHSNs within the AHSN Network are actively supporting the NHS and social care system regarding the Covid-19 pandemic.

If you would like advice on immediate or future needs, and how best to present your offer to local and/ or national commissioners, please contact us.

Support for innovators

The government has provided national guidance on where to register products to support the COVID-19 response. If you are a company or an innovator with a potential COVID-19 related solution, you can also contact the relevant national agency direct:

  • PPE (Personal Protection Equipment)                                                                                                        Contact the Surgical MedTech Co-operative (one of NIHR’s Medtech and In vitro diagnostics Co-operatives) if you have a technology that could be adapted quickly for the healthcare setting to help protect healthcare workers against aerosol contamination. Find out more about their ‘COVID-19 PPE Challenge’ here.
  • Vaccines
    Contact Public Health England: nervtag@phe.gov.uk
  • Ventilators
    Contact the Government’s Department for Business, Energy & Industrial Strategy (BEIS): ventilator.support@beis.gov.uk or call 0300 456 3565
  • Innovation and Tech
    Contact NHSX: DNHSX@nhsx.nhs.uk
    If you have a tech innovation that can support vulnerable people who are isolated, visit the NHSX TechForce19 website.
  • Diagnostics
    Contact Public Health England: coviddiagnostics@phe.gov.uk
  • General
    The UK government has set up a service allowing businesses to share any support that might help the COVID-19 response, from PPE and medical testing equipment to transport/logistics and warehouse space. Find out more here.

If you want to get in touch with us directly, please go through your usual contact or email contactus@weahsn.net.

If you have any other solutions (not specifically COVID-19 related) that could be useful to the health and care system during this unprecedented time, you can access AHSN advice and support by visiting the Innovation Exchange website.

Regional AHSN support

During this current period of extreme operational pressure, the West of England AHSN will be supporting our colleagues on the frontline and in planning and operations by offering the most appropriate assistance as and when required. This will include supporting the implementation of technology to maximise the use of remote consultations and online guidance, freeing up valuable clinician time and reducing the risk of transmission.

To date this support has involved:

We are working closely with our regional NHS teams to coordinate this support, but if you would like to speak to us, please do get in touch.

 

Posted on May 24, 2020

> Back to index